1-4 of 4
plexiform neurofibroma
Close
Save search
Sort by
Journal Articles

Mast cells and the neurofibroma microenvironment

Free
Karl Staser, Feng-Chun Yang, D. Wade Clapp
Journal: Blood
Blood (2010) 116 (2): 157–164.
https://doi.org/10.1182/blood-2009-09-242875
Published: 2010
Journal Articles

Mast Cells and Tumor Progression.

Free
D. Wade Clapp, MD, Fengchun Yang, MD, PhD, David A. Ingram, Jr., MD, Kent A. Robertson, MD, PhD, Gary D. Hutchins, PhD, Luis F. Parada, PhD
Journal: Blood
Blood (2009) 114 (22): SCI-33.
https://doi.org/10.1182/blood.V114.22.SCI-33.SCI-33
Published: 2009
Journal Articles

Imatinib Mesylate Reduces Plexiform Neurofibromas by Targeting the Hematopoietic Microenvironment.

Free
Feng-Chun Yang, MD, PhD, David Ingram, M.D., Shi Chen, M.D., Ph.D., Kent Robertson, M.D., Ph.D., Xiohong Li, Jin Yuan, Scott Knoll, Whitney Horn, Gary Hutchins, M.D., Ph.D., L. Parada, Ph.D., David Wade Clapp, M.D.
Journal: Blood
Blood (2007) 110 (11): 1915.
https://doi.org/10.1182/blood.V110.11.1915.1915
Published: 2007
Journal Articles

Mast Cells Are Integral Components of the Tumor Microenvironment That Are Required for Plexiform Neurofibroma Progression.

Free
Fengchun Yang, MD, PhD, David A. Ingram, MD, Shi Chen, MD, Jin Yuan, Xiaohong Li, Whitney Horn, Luis Parada, PhD, D. Wade Clapp, MD
Journal: Blood
Blood (2006) 108 (11): 677.
https://doi.org/10.1182/blood.V108.11.677.677
Published: 2006